Table 2. Results of ECP in Patients With... | American Society of Hematology

Table 2.

Results of ECP in Patients With Acute GVHD

Patient No.	Acute GVHD		Steroids Before ECP		Therapy at Start of ECP	Interval BMT-ECP (d)	No. of ECP Cycles	Duration of ECP (mo)	Response to ECP		Current Therapy	Time Off ECP (mo)
Patient No.	Grade	Onset (d)	Max. Dose (mg)	Duration (d)	Therapy at Start of ECP	Interval BMT-ECP (d)	No. of ECP Cycles	Duration of ECP (mo)	Skin	Liver	Current Therapy	Time Off ECP (mo)
1	II	12	4	14	CSA + MP	30	9	5	CR	NA	CSA	1
2	II	14	4	23	CSA + MP	37	9	5	CR	CR	CSA	1
3	III	18	3	29	CSA + MP	56	13	7	CR	NA	CSA	1
4	II	21	2	49	CSA + MP	70	12	9	CR	NA	NONE	17
5	III	15	10	22	CSA + MP	37	5	3	PR	NA	CSA	NA^*
6	III	13	2	32	CSA + MP	45	36	24	PR	CR	CSA	NA^*

Patient No.	Acute GVHD		Steroids Before ECP		Therapy at Start of ECP	Interval BMT-ECP (d)	No. of ECP Cycles	Duration of ECP (mo)	Response to ECP		Current Therapy	Time Off ECP (mo)
Patient No.	Grade	Onset (d)	Max. Dose (mg)	Duration (d)	Therapy at Start of ECP	Interval BMT-ECP (d)	No. of ECP Cycles	Duration of ECP (mo)	Skin	Liver	Current Therapy	Time Off ECP (mo)
1	II	12	4	14	CSA + MP	30	9	5	CR	NA	CSA	1
2	II	14	4	23	CSA + MP	37	9	5	CR	CR	CSA	1
3	III	18	3	29	CSA + MP	56	13	7	CR	NA	CSA	1
4	II	21	2	49	CSA + MP	70	12	9	CR	NA	NONE	17
5	III	15	10	22	CSA + MP	37	5	3	PR	NA	CSA	NA^*
6	III	13	2	32	CSA + MP	45	36	24	PR	CR	CSA	NA^*

Abbreviations: Max, maximum; CSA, cyclosporine A; MP, methylprednisolone; CR, complete remission; PR, partial remission; NA, not applicable; NA*, still under ECP.